Menu
30/10/2013
Queen's Joins Cystic Fibrosis Research Programme
Scientists at Queen's University Belfast are taking part in a new €6m bid to find treatments for Cystic Fibrosis.
Professor Stuart Elborn will lead the study at Queen's University, which is the lead partner in the new research programme.
Affecting more than 10,000 people in the UK, Cystic Fibrosis (CF) is one of the most common life-threatening inherited diseases.
The new global programme, known as CF Matters, aims to develop personalised antibiotic treatments for the chest infections that are commonly caused by the disease.
The study brings together renowned CF clinicians and scientists from 12 academic institutions and hospitals across Europe and the USA.
It is led by University College Cork with Queen’s as a lead partner. It will involve lab-based research and clinical trials with 252 patients in seven countries, including around 40 in Northern Ireland.
Queen's lead on the study is Professor Stuart Elborn, Director of Queen's Centre for Infection and Immunity.
He said: "When patients have a flare-up they are treated with several antibiotics but it isn’t always effective and can lead to antibiotic resistance. In this study we will use molecular next generation DNA sequencing methods to detect all the bacteria present in the sputum of CF patients and use this knowledge to determine what antibiotics should be used in individual patients.
"This personalised antibiotic treatment will be compared with standard therapy for CF patients. We will determine the patient’s immune response to all the different bacteria present in the sputum. Using models of infection we will also discover the effect of these bacteria on lung inflammation and infection. The overall impact will be to determine if all bacteria present contribute significantly to lung infection in CF patients and subsequently identify the most effective antibiotic treatment for patients infected with these bacteria."
The study will involve a team of scientists from Queen's Centre for Infection and Immunity including Professor Cliff Taggart, Dr Rebecca Ingram and Dr Sinéad Weldon and Dr Michael Tunney from the School of Pharmacy.
(IT/CD)
Professor Stuart Elborn will lead the study at Queen's University, which is the lead partner in the new research programme.
Affecting more than 10,000 people in the UK, Cystic Fibrosis (CF) is one of the most common life-threatening inherited diseases.
The new global programme, known as CF Matters, aims to develop personalised antibiotic treatments for the chest infections that are commonly caused by the disease.
The study brings together renowned CF clinicians and scientists from 12 academic institutions and hospitals across Europe and the USA.
It is led by University College Cork with Queen’s as a lead partner. It will involve lab-based research and clinical trials with 252 patients in seven countries, including around 40 in Northern Ireland.
Queen's lead on the study is Professor Stuart Elborn, Director of Queen's Centre for Infection and Immunity.
He said: "When patients have a flare-up they are treated with several antibiotics but it isn’t always effective and can lead to antibiotic resistance. In this study we will use molecular next generation DNA sequencing methods to detect all the bacteria present in the sputum of CF patients and use this knowledge to determine what antibiotics should be used in individual patients.
"This personalised antibiotic treatment will be compared with standard therapy for CF patients. We will determine the patient’s immune response to all the different bacteria present in the sputum. Using models of infection we will also discover the effect of these bacteria on lung inflammation and infection. The overall impact will be to determine if all bacteria present contribute significantly to lung infection in CF patients and subsequently identify the most effective antibiotic treatment for patients infected with these bacteria."
The study will involve a team of scientists from Queen's Centre for Infection and Immunity including Professor Cliff Taggart, Dr Rebecca Ingram and Dr Sinéad Weldon and Dr Michael Tunney from the School of Pharmacy.
(IT/CD)
Related Northern Ireland News Stories
Click here for the latest headlines.
09 April 2024
Minister Calls For Action To Address Decline Of NI Bird Of Prey
Department of Agriculture, the Environment and Rural Affairs (DAERA) Minister, Andrew Muir, has called for urgent action to address the decline of one of Northern Ireland's rarest birds of prey. A new DAERA part-funded survey has revealed that the Hen Harrier, a priority species in Northern Ireland, has declined by more than 26% since 2016.
Minister Calls For Action To Address Decline Of NI Bird Of Prey
Department of Agriculture, the Environment and Rural Affairs (DAERA) Minister, Andrew Muir, has called for urgent action to address the decline of one of Northern Ireland's rarest birds of prey. A new DAERA part-funded survey has revealed that the Hen Harrier, a priority species in Northern Ireland, has declined by more than 26% since 2016.
23 February 2024
QUB Launch Immersive Conflict Resolution Training Programme
Queen's University Belfast has announced a partnership with Mediation Northern Ireland for a new, first-of-its-kind, immersive conflict resolution training programme.
QUB Launch Immersive Conflict Resolution Training Programme
Queen's University Belfast has announced a partnership with Mediation Northern Ireland for a new, first-of-its-kind, immersive conflict resolution training programme.
14 February 2024
Former City Centre Police Station To Become New 74-Bedroom Hotel
A former police station in Belfast city centre is to be redeveloped for a new 74-bedroom hotel. Belfast City Council's Planning Committee approved the development on Queen Street, along with granting Listed Building Consent to bring the building into use again.
Former City Centre Police Station To Become New 74-Bedroom Hotel
A former police station in Belfast city centre is to be redeveloped for a new 74-bedroom hotel. Belfast City Council's Planning Committee approved the development on Queen Street, along with granting Listed Building Consent to bring the building into use again.
15 March 2022
Over 1,700 Patients Receiving Ground-Breaking Covid-19 Treatments
More than 1,700 patients at highest risk of serious illness across NI have received ground-breaking Covid-19 treatments. The patients have received neutralising monoclonal antibody (nMAB) and antiviral treatments at Health and Social Care (HSC) Trust Outpatient COVID-19 Treatment services (OCTs), or oral antiviral medicine to take at home.
Over 1,700 Patients Receiving Ground-Breaking Covid-19 Treatments
More than 1,700 patients at highest risk of serious illness across NI have received ground-breaking Covid-19 treatments. The patients have received neutralising monoclonal antibody (nMAB) and antiviral treatments at Health and Social Care (HSC) Trust Outpatient COVID-19 Treatment services (OCTs), or oral antiviral medicine to take at home.
15 June 2021
Health Minister Applauds Vaccination Take-Up Initiatives
Initiatives to support vaccination take-up have been applauded by Health Minister Robin Swann. A targeted programme of pop-up clinics is being rolled out to different locations in Northern Ireland, helping local communities access vaccines.
Health Minister Applauds Vaccination Take-Up Initiatives
Initiatives to support vaccination take-up have been applauded by Health Minister Robin Swann. A targeted programme of pop-up clinics is being rolled out to different locations in Northern Ireland, helping local communities access vaccines.
-
Northern Ireland WeatherToday:A mostly cloudy start with scattered showers, the showers becoming more isolated and largely confined to the south this morning. Becoming brighter this afternoon, the best of any sunnier spells across northern counties. Northerly winds easing. Maximum temperature 12 °C.Tonight:A dry evening with late sunny spells and some long clear spells overnight. Becoming cloudier across the north towards dawn with a few showers possible. Touch of frost in south. Minimum temperature 0 °C.
